Defining success after surgery for pelvic organ prolapse
- PMID: 19701041
- PMCID: PMC2904469
- DOI: 10.1097/AOG.0b013e3181b2b1ae
Defining success after surgery for pelvic organ prolapse
Abstract
Objectives: To describe pelvic organ prolapse surgical success rates using a variety of definitions with differing requirements for anatomic, symptomatic, or re-treatment outcomes.
Methods: Eighteen different surgical success definitions were evaluated in participants who underwent abdominal sacrocolpopexy within the Colpopexy and Urinary Reduction Efforts trial. The participants' assessments of overall improvement and rating of treatment success were compared between surgical success and failure for each of the definitions studied. The Wilcoxon rank sum test was used to identify significant differences in outcomes between success and failure.
Results: Treatment success varied widely depending on definition used (19.2-97.2%). Approximately 71% of the participants considered their surgery "very successful," and 85.2% considered themselves "much better" than before surgery. Definitions of success requiring all anatomic support to be proximal to the hymen had the lowest treatment success (19.2-57.6%). Approximately 94% achieved surgical success when it was defined as the absence of prolapse beyond the hymen. Subjective cure (absence of bulge symptoms) occurred in 92.1% while absence of re-treatment occurred in 97.2% of participants. Subjective cure was associated with significant improvements in the patient's assessment of both treatment success and overall improvement, more so than any other definition considered (P<.001 and <.001, respectively). Similarly, the greatest difference in symptom burden and health-related quality of life as measured by the Pelvic Organ Prolapse Distress Inventory and Pelvic Organ Prolapse Impact Questionnaire scores between treatment successes and failures was noted when success was defined as subjective cure (P<.001).
Conclusion: The definition of success substantially affects treatment success rates after pelvic organ prolapse surgery. The absence of vaginal bulge symptoms postoperatively has a significant relationship with a patient's assessment of overall improvement, while anatomic success alone does not.
Level of evidence: II.
Trial registration: ClinicalTrials.gov NCT00065845.
Figures
Comment in
-
Words of wisdom. Re: defining success after surgery for pelvic organ prolapse.Eur Urol. 2010 Oct;58(4):633-4. doi: 10.1016/j.eururo.2010.07.017. Eur Urol. 2010. PMID: 20848728 No abstract available.
References
-
- Brubaker L, Bump RC, Fynes M, Jacquetin B, Karram M, Kreder K, et al. In: Abrams P, Cordozo L, Koury S, Wein A, editors. Surgery for pelvic organ prolapse; 3rd international consultation on incontinence; Paris: Health Publication Ltd; 2005. pp. 1371–1401.
-
- Maher C, Baessler K, Glazener CM, Adams EJ, Hagen S. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2004:CD004014. - PubMed
-
- Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175:10–7. - PubMed
-
- Swift S, Woodman P, O’Boyle A, Kahn M, Valley M, Bland D, et al. Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. Am J Obstet Gynecol. 2005;192:795–806. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- U10 HD041261/HD/NICHD NIH HHS/United States
- U10 HD054215/HD/NICHD NIH HHS/United States
- U10 HD054214/HD/NICHD NIH HHS/United States
- U10 HD 41267/HD/NICHD NIH HHS/United States
- U10 HD 54214/HD/NICHD NIH HHS/United States
- U10 HD041263/HD/NICHD NIH HHS/United States
- U10 HD041267/HD/NICHD NIH HHS/United States
- U10 HD041248/HD/NICHD NIH HHS/United States
- U01 HD 41249/HD/NICHD NIH HHS/United States
- U10 HD 41261/HD/NICHD NIH HHS/United States
- U01 HD041249/HD/NICHD NIH HHS/United States
- U10 HD 54136/HD/NICHD NIH HHS/United States
- U10 HD 41250/HD/NICHD NIH HHS/United States
- UG1 HD041267/HD/NICHD NIH HHS/United States
- U10 HD054136/HD/NICHD NIH HHS/United States
- U10 HD 54215/HD/NICHD NIH HHS/United States
- U10 HD041269/HD/NICHD NIH HHS/United States
- U10 HD041268/HD/NICHD NIH HHS/United States
- U10 HD054241/HD/NICHD NIH HHS/United States
- U10 HD041250/HD/NICHD NIH HHS/United States
- U10 HD 54241/HD/NICHD NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
